Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry

被引：1
|
作者：
Kirchmeier, Delaney R. [1 ]
Sheih, Alyssa [2 ,3 ]
Fiorenza, Salvatore [3 ]
Hirayama, Alexandre V. [3 ]
Chou, Cassie [3 ,4 ]
Kimble, Erik [3 ,5 ]
Gauthier, Jordan [3 ]
Williams, Alison [3 ]
Price, Jason [3 ]
Correnti, Colin [3 ,6 ]
Turtle, Cameron J. [3 ,5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Umoja Biopharma, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Univ Washington, Dept Med, Seattle, WA USA
[6] Link Immunotherapeut, Seattle, WA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1724
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
    Nathaniel D. Anderson
    Jack Birch
    Theo Accogli
    Ignacio Criado
    Eleonora Khabirova
    Conor Parks
    Yvette Wood
    Matthew D. Young
    Tarryn Porter
    Rachel Richardson
    Sarah J. Albon
    Bilyana Popova
    Andre Lopes
    Robert Wynn
    Rachael Hough
    Satyen H. Gohil
    Martin Pule
    Persis J. Amrolia
    Sam Behjati
    Sara Ghorashian
    Nature Medicine, 2023, 29 : 1700 - 1709
  • [32] Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells
    Mika, Thomas
    Maghnouj, Abdelouahid
    Klein-Scory, Susanne
    Ladigan-Badura, Swetlana
    Baraniskin, Alexander
    Thomson, Julia
    Hasenkamp, Justin
    Hahn, Stephan A.
    Wulf, Gerald
    Schroers, Roland
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [33] Development of a translatable CD19 CAR-T platform for drug discovery
    Kelsey, Lauren
    Self-Fordham, Jezrom
    Oswald, Eva
    Aylott, Ilona
    Rocca, Daniel
    Nunan, Robert
    Harris, David
    Schueler, Julia
    Jenkinson, Rhiannon
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
    Anderson, Nathaniel D.
    Birch, Jack
    Accogli, Theo
    Criado, Ignacio
    Khabirova, Eleonora
    Parks, Conor
    Wood, Yvette
    Young, Matthew D.
    Porter, Tarryn
    Richardson, Rachel
    Albon, Sarah J.
    Popova, Bilyana
    Lopes, Andre
    Wynn, Robert
    Hough, Rachael
    Gohil, Satyen H.
    Pule, Martin
    Amrolia, Persis J.
    Behjati, Sam
    Ghorashian, Sara
    NATURE MEDICINE, 2023, 29 (07) : 1700 - +
  • [35] Two years later: CD19 CAR-T going the distance
    Darnell, Eli P.
    Frigault, Matthew J.
    BLOOD, 2024, 143 (05) : 379 - 380
  • [36] Synergistic effect of ibrutinib and CD19 CAR-T cells on Raji cells in vivo and in vitro
    Liu, Meijing
    Wang, Xuelin
    Li, Zheng
    Zhang, Rui
    Mu, Juan
    Jiang, Yanyu
    Deng, Qi
    Sun, Lei
    CANCER SCIENCE, 2020, 111 (11) : 4051 - 4060
  • [37] CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report
    Sun, Yao
    Su, Yongfeng
    Wang, Yizhi
    Liu, Na
    Li, Yuhang
    Chen, Jianlin
    Qiao, Zhuoqing
    Niu, Jingwen
    Hu, Jiangwei
    Zhang, Bin
    Ning, Hongmei
    Hu, Liangding
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] Analysis of CD19.CAR-T cells by flow cytometry and PCR
    Schanda, N.
    Kunz, A.
    Sauer, T.
    Schubert, M. -L
    Korell, F.
    Hueckelhoven-Krauss, A.
    Neuber, B.
    Hinkelbein, M.
    Mueller-Tidow, C.
    Schmitt, M.
    Schmitt, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 259 - 259
  • [39] Obese microenvironments attenuate the efficacy of endogenous and CD19-directed CAR T-cells
    Ank, Raira Silva
    Henry, Curtis J.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [40] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    ONCOLOGY LETTERS, 2021, 22 (05)
12345